CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers (Q37318768)

19 August 2017

1 reference

title

CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers (English)

1 reference

19 August 2017

1 reference

J A Burger

1

1 reference

PubMed ID

18987663

19 August 2017

A Peled

series ordinal

2

1 reference

19 August 2017

6 November 2008

1 reference

19 August 2017

1 reference

19 August 2017

23

1 reference

19 August 2017

1

1 reference

19 August 2017

43-52

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2008.299

19 August 2017

0 references

cites work

Stromal fibroblasts in cancer: a novel tumor-promoting cell type

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

HIF-1: an oxygen and metal responsive transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

A role of CXC chemokine ligand 12/stromal cell-derived factor-1/pre-B cell growth stimulating factor and its receptor CXCR4 in fetal and adult T cell development in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

Chemokines: a new classification system and their role in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Chemokines and leukocyte traffic

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Lymphocyte traffic control by chemokines

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Molecular cloning and structure of a pre-B-cell growth-stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Control of chemokine-guided cell migration by ligand sequestration

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Involvement of chemokine receptors in breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Hematopoietic stem cells are uniquely selective in their migratory response to chemokines

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Stem cells and their niches

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Stem cells and niches: mechanisms that promote stem cell maintenance throughout life

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Stem cell trafficking in tissue development, growth, and disease

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

A coordinated change in chemokine responsiveness guides plasma cell movements

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Homing of antibody secreting cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

A perivascular niche for brain tumor stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Hit 'em where they live: targeting the cancer stem cell niche

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

AMD3100: CXCR4 antagonist and rapid stem cell-mobilizing agent

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-benzoyl-TN14003.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Local delivery of protease-resistant stromal cell derived factor-1 for stem cell recruitment after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

The CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

An attractive force in metastasis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Tumor microenvironment and drug resistance in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Factor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

CXCR4 chemokine receptors (CD184) and alpha4beta1 integrins mediate spontaneous migration of human CD34+ progenitors and acute myeloid leukaemia cells beneath marrow stromal cells (pseudoemperipolesis).

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Safe use of the CXCR4 inhibitor ALX40-4C in humans

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

A small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Lipid bilayer simulations of CXCR4 with inverse agonists and weak partial agonists

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

A single treatment with microcapsules containing a CXCR4 antagonist suppresses pulmonary metastasis of murine melanoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Identification of a CXCR4 antagonist, a T140 analog, as an anti-rheumatoid arthritis agent

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Effects of inhibitors of the chemokine receptor CXCR4 on acute lymphoblastic leukemia cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Development of plasmacytoid dendritic cells in bone marrow stromal cell niches requires CXCL12-CXCR4 chemokine signaling.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

The bicyclam AMD3100 story

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Characterization of the molecular pharmacology of AMD3100: a specific antagonist of the G-protein coupled chemokine receptor, CXCR4.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

CD4-independent infection by HIV-2 is mediated by fusin/CXCR4.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Antigenically distinct conformations of CXCR4.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

The role of post-translational modifications of the CXCR4 amino terminus in stromal-derived factor 1 alpha association and HIV-1 entry

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

CD34+ marrow progenitors from MDS patients with high levels of intramedullary apoptosis have reduced expression of alpha4beta1 and alpha5beta1 integrins

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Motility, proliferation, and egress to the circulation of human AML cells are elastase dependent in NOD/SCID chimeric mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Human acute myeloid leukemia stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

CXCR4 is a prognostic marker in acute myelogenous leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Microenvironmental niches in the bone marrow required for B-cell development

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1- and CD106 (VCAM-1)-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Chemokine receptor expression and function in childhood acute lymphoblastic leukemia of B-lineage

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Unique SDF-1-induced activation of human precursor-B ALL cells as a result of altered CXCR4 expression and signaling

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

A new mechanism of leukemia drug resistance?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

CXCR4 regulates growth of both primary and metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Human melanoma metastases express functional CXCR4.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Sensitization of B16 tumor cells with a CXCR4 antagonist increases the efficacy of immunotherapy for established lung metastases.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

SDF-1 and CXCR4 are up-regulated by VEGF and contribute to glioma cell invasion.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Invasive characteristics of human prostatic epithelial cells: understanding the metastatic process

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.299

7 January 2021

Identifiers

DOI

10.1038/LEU.2008.299

1 reference

19 August 2017

1 reference

PubMed ID

18987663